What is the appropriate acute and preventive treatment for a patient with typical episodic or chronic cluster headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cluster Headache Treatment

Acute Treatment

For acute cluster headache attacks, use subcutaneous sumatriptan 6 mg or 100% oxygen at 12 L/min for 15 minutes as first-line therapy, with subcutaneous sumatriptan being the most effective pharmacologic option (74-75% relief within 15 minutes). 1

First-Line Acute Options

  • Subcutaneous sumatriptan 6 mg is the gold standard acute treatment, achieving headache relief in 74-75% of patients within 15 minutes 1, 2
  • 100% oxygen at 12 L/min for 15 minutes is equally first-line and has no cardiovascular contraindications, making it safer for patients with cardiac risk factors 1, 3

Second-Line Acute Options (when first-line not tolerated or unavailable)

  • Intranasal zolmitriptan 10 mg achieves no or mild pain in 28% of patients by 15 minutes 1, 3
  • Intranasal sumatriptan 20 mg is less effective than subcutaneous formulation, with approximately 40% of responders experiencing recurrence within 24 hours (a second dose can be administered if headache recurs) 3, 1

Critical Contraindications for Triptans

  • Screen for ischemic heart disease, Prinzmetal's angina, uncontrolled hypertension, Wolff-Parkinson-White syndrome, and history of stroke or TIA before prescribing triptans 1
  • Do not use triptans concurrently with ergotamine derivatives due to additive vasoconstrictive effects 3
  • Limit triptan use to ≤10 days per month to prevent medication overuse headache 1

Preventive Treatment

For episodic cluster headache prevention, galcanezumab is the first-line prophylactic treatment with the strongest available evidence, while verapamil remains a traditional option despite insufficient guideline-level evidence. 4, 1

First-Line Preventive Therapy

  • Galcanezumab has the strongest evidence for episodic cluster headache prevention according to 2023 VA/DoD guidelines (weak recommendation FOR) 4, 1
  • Monitor for injection site reactions and hypersensitivity with galcanezumab 4

Important Preventive Treatment Distinctions

  • Do NOT use galcanezumab for chronic cluster headache (attacks >1 year without remission)—it has a weak recommendation AGAINST in this population 4
  • Verapamil is traditionally considered the mainstay of prophylactic therapy, though 2023 VA/DoD guidelines state there is insufficient evidence to recommend for or against it for either episodic or chronic cluster headache 4, 2

Bridge Therapy

  • Corticosteroids (oral or suboccipital injections) provide short-term fast-acting prevention while establishing maintenance prophylaxis 2, 5
  • This transitional approach prevents attacks during the initiation period of slower-acting preventive medications 2

Treatment Algorithm

For Acute Attacks:

  1. Start with subcutaneous sumatriptan 6 mg OR 100% oxygen at 12 L/min for 15 minutes (choose oxygen if cardiovascular contraindications exist) 1
  2. If subcutaneous sumatriptan is not tolerated or practical, use intranasal zolmitriptan 10 mg 1
  3. If both above fail or are unavailable, use intranasal sumatriptan 20 mg 3, 1

For Prevention:

  1. For episodic cluster headache: Start galcanezumab as first-line prophylaxis 4, 1
  2. For chronic cluster headache: Do NOT use galcanezumab; consider verapamil, lithium, or other options 4
  3. Bridge therapy: Use corticosteroids during prophylaxis initiation 2
  4. Ensure acute treatments (oxygen, triptans) are available for breakthrough attacks 4

Common Pitfalls to Avoid

  • Do not confuse acute and prophylactic treatments—oxygen and sumatriptan treat individual attacks, not prevention 4
  • Do not use galcanezumab if the patient has chronic cluster headache (continuous attacks >1 year without remission) 4
  • Do not combine triptans with ergotamine derivatives due to additive vasoconstrictive effects 3
  • Do not use triptans concurrently with other triptans—allow adequate washout period 3
  • Do not exceed 10 days per month of triptan use to prevent medication overuse headache 1

Special Considerations

  • Cluster headache requires rapid-acting, non-oral routes for acute treatment due to the quick peak of pain 2
  • Attacks frequently occur at night and have distinctive circadian/circannual periodicity in episodic forms 2, 6
  • For medically refractory chronic cluster headache, neuromodulation options (occipital nerve stimulation, vagus nerve stimulation, deep brain stimulation) may be considered 2, 7

References

Guideline

Acute Treatment of Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Guideline

Intranasal Sumatriptan for Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Prophylactic Treatment for Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of cluster headache.

Seminars in neurology, 2006

Research

Cluster headache: diagnosis and treatment.

Seminars in neurology, 2010

Research

Cluster headache: present and future therapy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.